Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Admicom Oyj ADMCM Feb 21, 2020 89.00 -0.89   
 Afarak Group AFAGR Feb 21, 2020 0.46 -1.82   
 Ahlstrom-Munksjö AM1 Feb 21, 2020 14.12 -0.56   
 Ahlstrom-Munksjö AM1S Feb 21, 2020 149.20 -0.80   
 Ahola Transport AHOLA Feb 21, 2020 0.96 +1.05   
 Aktia Bank AKTIA Feb 21, 2020 11.22 -1.23   
 Alma Media ALMA Feb 21, 2020 8.96 +0.45   
 Altia ALTIA Feb 21, 2020 8.56 -1.50   
 Apetit APETIT Feb 21, 2020 8.66 -0.46   
 Asiakastieto Group ATG1V Feb 21, 2020 32.60 +1.56   
 Aspo ASPO Feb 21, 2020 8.26 +0.24   
 Aspocomp Group ACG1V Feb 21, 2020 5.46 -1.09   
 Atria A ATRAV Feb 21, 2020 9.42 -3.68   
 Basware BAS1V Feb 21, 2020 28.00 -0.89   
 BBS-Bioactive Bone Substitutes BONEH Feb 21, 2020 9.15 -14.49   
 Biohit B BIOBV Feb 21, 2020 3.14 -2.18   
 Bittium BITTI Feb 21, 2020 6.31 0.00   
 CapMan CAPMAN Feb 21, 2020 2.84 -1.05   
 Cargotec CGCBV Feb 21, 2020 30.46 -0.13   
 Caverion CAV1V Feb 21, 2020 6.61 -1.49   
 Citycon CTY1S Feb 21, 2020 9.69 +0.62   
 Componenta CTH1V Feb 21, 2020 0.11 +0.46   
 Consti Yhtiöt CONSTI Feb 21, 2020 8.10 +0.25   
 Cramo CRA1V Feb 21, 2020 13.76 -1.85   
 Detection Technology DETEC Feb 21, 2020 22.60 +0.89   
 Digia DIGIA Feb 21, 2020 5.02 +0.60   
 Digitalist Group DIGIGR Feb 21, 2020 0.04 -2.79   
 Dovre Group DOV1V Feb 21, 2020 0.33 -4.61   
 EAB Group EAB Feb 21, 2020 3.00 -1.96   
 Efecte PLC EFECTE Feb 21, 2020 6.02 -1.31   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK